National Health Investors, Inc. (NYSE:NHI) Declares $0.90 Quarterly Dividend

National Health Investors, Inc. (NYSE:NHI) announced a quarterly dividend on Tuesday, November 5th, Wall Street Journal reports. Investors of record on Tuesday, December 31st will be given a dividend of 0.90 per share by the real estate investment trust on Wednesday, January 29th. This represents a $3.60 annualized dividend and a yield of 4.69%. The ex-dividend date is Tuesday, December 31st.

National Health Investors has increased its dividend payment by an average of 0.9% per year over the last three years. National Health Investors has a payout ratio of 115.0% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Research analysts expect National Health Investors to earn $4.66 per share next year, which means the company should continue to be able to cover its $3.60 annual dividend with an expected future payout ratio of 77.3%.

National Health Investors Stock Up 0.0 %

NHI opened at $76.76 on Thursday. National Health Investors has a twelve month low of $49.25 and a twelve month high of $86.13. The firm has a market cap of $3.34 billion, a P/E ratio of 26.11, a price-to-earnings-growth ratio of 5.05 and a beta of 1.05. The business has a 50 day moving average price of $80.38 and a 200 day moving average price of $73.16. The company has a debt-to-equity ratio of 0.91, a quick ratio of 10.27 and a current ratio of 10.27.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The business had revenue of $63.32 million for the quarter, compared to analyst estimates of $67.93 million. During the same quarter last year, the firm earned $1.08 earnings per share. The firm’s quarterly revenue was up 1.7% compared to the same quarter last year. Research analysts forecast that National Health Investors will post 4.48 EPS for the current year.

Analyst Ratings Changes

NHI has been the subject of a number of research analyst reports. Wells Fargo & Company lowered National Health Investors from an “overweight” rating to an “equal weight” rating and upped their price target for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Bank of America initiated coverage on National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective on the stock. Finally, Truist Financial boosted their price objective on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research report on Friday, August 30th. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $73.29.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.